Small Cell Bladder Cancer Response to Second-line and Beyond Checkpoint Inhibitor Therapy: Retrospective Experience

被引：10

作者：

Hoffman-Censits, Jean ^{[1
]}

Choi, Woonyoung ^{[2
,3
]}

Bivalacqua, Trinity J. ^{[2
,3
]}

Pierorazio, Philip ^{[2
,3
]}

Kates, Max ^{[2
,3
]}

Lombardo, Kara ^{[2
,3
]}

Parini, Vamsi ^{[4
]}

McConkey, David ^{[2
,3
]}

Trabulsi, Edouard J. ^{[7
]}

Hahn, Noah ^{[1
]}

Matoso, Andres ^{[4
,5
,6
]}

机构：

[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[2] James Buchanan Brady Urol Inst, Baltimore, MD USA

[3] Dept Urol, Baltimore, MD USA

[4] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA

[5] Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21205 USA

[6] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA

[7] Thomas Jefferson Univ, Dept Urol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA

来源：

CLINICAL GENITOURINARY CANCER | 2021年 / 19卷 / 02期

关键词：

Immunotherapy; Neuroendocrine cancer; Platinum refractory cancer; Upper tract; Variant histology; PHASE-II; LUNG-CANCER; CARCINOMA; CHEMOTHERAPY; DNA; ETOPOSIDE/CISPLATIN; PEMBROLIZUMAB; CISPLATIN; ETOPOSIDE; OUTCOMES;

D O I：

10.1016/j.clgc.2020.10.009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：176 / 181

页数：6

共 33 条

[1] Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study [J].

Apolo, Andrea B. ;

Infante, Jeffrey R. ;

Balmanoukian, Ani ;

Patel, Manish R. ;

Wang, Ding ;

Kelly, Karen ;

Mega, Anthony E. ;

Britten, Carolyn D. ;

Ravaud, Alain ;

Mita, Alain C. ;

Safran, Howard ;

Stinchcombe, Thomas E. ;

Srdanov, Marko ;

Gelb, Arnold B. ;

Schlichting, Michael ;

Chin, Kevin ;

Gulley, James L. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) :2117-+

[2] First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study [J].

Balar, Arjun V. ;

Castellano, Daniel ;

O'Donnell, Peter H. ;

Grivas, Petros ;

Vuky, Jacqueline ;

Powles, Thomas ;

Plimack, Elizabeth R. ;

Hahn, Noah M. ;

de Wit, Ronald ;

Pang, Lei ;

Savage, Mary J. ;

Perini, Rodolfo F. ;

Keefe, Stephen M. ;

Bajorin, Dean ;

Bellmunt, Joaquim .

LANCET ONCOLOGY, 2017, 18 (11) :1483-1492

[3] Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial [J].

Balar, Arjun V. ;

Galsky, Matthew D. ;

Rosenberg, Jonathan E. ;

Powles, Thomas ;

Petrylak, Daniel P. ;

Bellmunt, Joaquim ;

Loriot, Yohann ;

Necchi, Andrea ;

Hoffman-Censits, Jean ;

Perez-Gracia, Jose Luis ;

Dawson, Nancy A. ;

van der Heijden, Michiel S. ;

Dreicer, Robert ;

Srinivas, Sandy ;

Retz, Margitta M. ;

Joseph, Richard W. ;

Drakaki, Alexandra ;

Vaishampayan, Ulka N. ;

Sridhar, Srikala S. ;

Quinn, David I. ;

Duran, Ignacio ;

Shaffer, David R. ;

Eigl, Bernhard J. ;

Grivas, Petros D. ;

Yu, Evan Y. ;

Li, Shi ;

Kadel, Edward E., III ;

Boyd, Zachary ;

Bourgon, Richard ;

Hegde, Priti S. ;

Mariathasan, Sanjeev ;

Thastrom, AnnChristine ;

Abidoye, Oyewale O. ;

Fine, Gregg D. ;

Bajorin, Dean F. .

LANCET, 2017, 389 (10064) :67-76

[4] Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma [J].

Bellmunt, J. ;

de Wit, R. ;

Vaughn, D. J. ;

Fradet, Y. ;

Lee, J. -L. ;

Fong, L. ;

Vogelzang, N. J. ;

Climent, M. A. ;

Petrylak, D. P. ;

Choueiri, T. K. ;

Necchi, A. ;

Gerritsen, W. ;

Gurney, H. ;

Quinn, D. I. ;

Culine, S. ;

Sternberg, C. N. ;

Mai, Y. ;

Poehlein, C. H. ;

Perini, R. F. ;

Bajorin, D. F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (11) :1015-1026

[5] Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis [J].

Birkenkamp-Demtroder, Karin ;

Christensen, Emil ;

Nordentoft, Iver ;

Knudsen, Michael ;

Taber, Ann ;

Hoyer, Soren ;

Lamy, Philippe ;

Agerbaek, Mads ;

Jensen, Jorgen Bjerggaard ;

Dyrskjot, Lars .

EUROPEAN UROLOGY, 2018, 73 (04) :535-540

[6] Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis [J].

Chang, Matthew T. ;

Penson, Alexander ;

Desai, Neil B. ;

Socci, Nicholas D. ;

Shen, Ronglai ;

Seshan, Venkatraman E. ;

Kundra, Ritika ;

Abeshouse, Adam ;

Viale, Agnes ;

Cha, Eugene K. ;

Hao, Xueli ;

Reuter, Victor E. ;

Rudin, Charles M. ;

Bochner, Bernard H. ;

Rosenberg, Jonathan E. ;

Bajorin, Dean F. ;

Schultz, Nikolaus ;

Berger, Michael F. ;

Iyer, Gopa ;

Solit, David B. ;

Al-Ahmadie, Hikmat A. ;

Taylor, Barry S. .

CLINICAL CANCER RESEARCH, 2018, 24 (08) :1965-1973

[7] Comprehensive genomic profiles of small cell lung cancer [J].

George, Julie ;

Lim, Jing Shan ;

Jang, Se Jin ;

Cun, Yupeng ;

Ozretic, Luka ;

Kong, Gu ;

Leenders, Frauke ;

Lu, Xin ;

Fernandez-Cuesta, Lynnette ;

Bosco, Graziella ;

Mueller, Christian ;

Dahmen, Ilona ;

Jahchan, Nadine S. ;

Park, Kwon-Sik ;

Yang, Dian ;

Karnezis, Anthony N. ;

Vaka, Dedeepya ;

Torres, Angela ;

Wang, Maia Segura ;

Korbel, Jan O. ;

Menon, Roopika ;

Chun, Sung-Min ;

Kim, Deokhoon ;

Wilkerson, Matt ;

Hayes, Neil ;

Engelmann, David ;

Puetzer, Brigitte ;

Bos, Marc ;

Michels, Sebastian ;

Vlasic, Ignacija ;

Seidel, Danila ;

Pinther, Berit ;

Schaub, Philipp ;

Becker, Christian ;

Altmueller, Janine ;

Yokota, Jun ;

Kohno, Takashi ;

Iwakawa, Reika ;

Tsuta, Koji ;

Noguchi, Masayuki ;

Muley, Thomas ;

Hoffmann, Hans ;

Schnabel, Philipp A. ;

Petersen, Iver ;

Chen, Yuan ;

Soltermann, Alex ;

Tischler, Verena ;

Choi, Chang-min ;

Kim, Yong-Hee ;

Massion, Pierre P. .

NATURE, 2015, 524 (7563) :47-53

[8] Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma [J].

Geynisman, Daniel M. ;

Handorf, Elizabeth ;

Wong, Yu-Ning ;

Doyle, Jamie ;

Plimack, Elizabeth R. ;

Horwitz, EricM. ;

Canter, Daniel J. ;

Uzzo, Robert G. ;

Kutikov, Alexander ;

Smaldone, Marc C. .

CANCER MEDICINE, 2016, 5 (02) :192-199

[9]

Hoffman-Censits J, 2020, EUR UROL ONCOL

[10] First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer [J].

Horn, L. ;

Mansfield, A. S. ;

Szczesna, A. ;

Havel, L. ;

Krzakowski, M. ;

Hochmair, M. J. ;

Huemer, F. ;

Losonczy, G. ;

Johnson, M. L. ;

Nishio, M. ;

Reck, M. ;

Mok, T. ;

Lam, S. ;

Shames, D. S. ;

Liu, J. ;

Ding, B. ;

Lopez-Chavez, A. ;

Kabbinavar, F. ;

Lin, W. ;

Sandler, A. ;

Liu, S. V. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (23) :2220-2229

← 1 2 3 4 →